Results 1 to 10 of about 103,321 (345)

Causes and Consequences of Hypertriglyceridemia [PDF]

open access: yesFrontiers in Endocrinology, 2020
Elevations in plasma triglyceride are the result of overproduction and impaired clearance of triglyceride-rich lipoproteins-very low-density lipoproteins (VLDL) and chylomicrons. Hypertriglyceridemia is characterized by an accumulation in the circulation of large VLDL-VLDL1-and its lipolytic products, and throughout the VLDL-LDL delipidation cascade ...
Chris J Packard, Marja-Riitta Taskinen
exaly   +7 more sources

Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke? [PDF]

open access: yesJournal of Stroke, 2022
Hypertriglyceridemia is caused by defects in triglyceride metabolism and generally manifests as abnormally high plasma triglyceride levels. Although the role of hypertriglyceridemia may not draw as much attention as that of plasma cholesterol in stroke ...
Hai-jie Liang   +4 more
doaj   +2 more sources

Genetics of Hypertriglyceridemia [PDF]

open access: yesFrontiers in Endocrinology, 2020
Hypertriglyceridemia, a commonly encountered phenotype in cardiovascular and metabolic clinics, is surprisingly complex. A range of genetic variants, from single-nucleotide variants to large-scale copy number variants, can lead to either the severe or mild-to-moderate forms of the disease.
Jacqueline S. Dron, Robert A. Hegele
openaire   +5 more sources

Hypertriglyceridemia in Gout [PDF]

open access: bronzeCirculation, 1964
Serum triglyceride levels were significantly higher in 34 patients with gout (42 mg. per 100 ml.) in comparison to the levels in 28 healthy men over 35 years of age (100 mg. per 100 ml.). There was no significant predictive relation between levels of serum uric acid and triglycerides in either group.
Elaine B. Feldman, Stanley L. Wallace
openalex   +4 more sources

The Genetic Basis of Hypertriglyceridemia [PDF]

open access: yesCurrent Atherosclerosis Reports, 2021
Abstract Purpose of Review Hypertriglyceridemia is a common dyslipidemia associated with an increased risk of cardiovascular disease and pancreatitis. Severe hypertriglyceridemia may sometimes be a monogenic condition.
Germán D. Carrasquilla   +2 more
openaire   +7 more sources

Hypertriglyceridemia and atherosclerosis [PDF]

open access: yesLipids in Health and Disease, 2017
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and it has been confirmed that increased low density lipoprotein cholesterol (LDL-C) is an independent risk factor for atherosclerosis. Recently, the increasing evidence has showed that hypertriglyceridemia is associated with incremental ASCVD risk.
Jia Peng   +4 more
openaire   +5 more sources

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

open access: hybridJournal of Lipid Research, 1983
Plasma lipoprotein concentration, composition, and size were evaluated in two common familial forms of hypertriglyceridemia and compared with those in normal subjects.
J D Brunzell   +5 more
doaj   +2 more sources

Identifying endemic areas and estimating the prevalence of hyperlipidemia in Taiwan's townships

open access: yesJournal of the Formosan Medical Association, 2021
Background/Purpose: This study aimed to evaluate geographic variations and differences in the prevalence of hypertriglyceridemia and hypercholesterolemia between Taiwan's townships. Methods: The prevalence of hypertriglyceridemia and hypercholesterolemia
Cheng-Feng Tsao   +5 more
doaj   +1 more source

Hypertriglyceridemia [PDF]

open access: yesNutrients, 2013
Hypertriglyceridemia (HTG) is commonly encountered in lipid and cardiology clinics. Severe HTG warrants treatment because of the associated increased risk of acute pancreatitis. However, the need to treat, and the correct treatment approach for patients with mild to moderate HTG are issues for ongoing evaluation.
Brahm, Amanda, Hegele, Robert A.
openaire   +2 more sources

Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy

open access: yesJournal of Infection in Developing Countries, 2022
Introduction: The objective of this study was to investigate changes in serum lipids among HIV-infected patients switching from non-nucleoside-reverse transcriptase inhibitors (NNRTI) to protease inhibitor (PI)-based highly active antiretroviral therapy
Yu Zhang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy